Cancer Vaccines Market Scope And Analysis

  • Report Code : TIPRE00004595
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Cancer Vaccines Market Analysis and Scope (2024 to 2031)

Buy Now

Cancer Vaccines Market Report Cancer Vaccines Market Size and Share Cancer Vaccines Market Scope and Analysis

Cancer Vaccines Market Report Scope

Report Attribute Details
Market size in 2021 US$ 5.68 Billion
Market Size by 2031 US$ 16.86 Billion
Global CAGR (2023 - 2031) 11.5%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Technology
  • Dendritic Cells Cancer Vaccines
  • Recombinant Cancer Vaccines
  • Antigen Cancer Vaccines
  • Whole Cell Cancer Vaccines
  • Viral Vector Cancer Vaccines
By Type
  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccines
By Indication
  • Cervical Cancer
  • Prostate Cancer
  • Other Indications
By End User
  • Pediatrics
  • Adults
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • CSL Limited
  • ADURO BIOTECH INC
  • Astellas Pharma Inc
  • Merck Co Inc
  • Sanofi
  • Bristol Myers Squibb Company
  • Glaxosmithkline Plc
  • Dendreon
  • ASTRAZENECA PLC
  • OSE Immunotherapeutics
    		•

    Cancer Vaccines Market News and Recent Developments

    The cancer vaccines market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for cancer vaccines and strategies:

    • In December 2023, Oxford University Hospitals launched new mRNA cancer vaccine trial for patients with head and neck cancers. (Source: Company Press Release)
    • In February 2024, Moderna’s cancer vaccine named mRNA-4359 trial begins at Imperial College Healthcare NHS Trust. The trial seeks to assess the safety and potential efficacy of the therapy in treating melanoma, lung cancer, and other solid tumor cancers
      (Source: Company Press Release)

    Cancer Vaccines Market Report Coverage and Deliverables

    The “Cancer Vaccines Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles